PubRank

Laura Sanz

Author PubWeight™ 24.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway and proinflammatory response in human pericytes. J Biol Chem 2013 1.23
2 Stathmin and interfacial microtubule inhibitors recognize a naturally curved conformation of tubulin dimers. J Biol Chem 2010 1.15
3 Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. J Leukoc Biol 2002 1.14
4 Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds. Stem Cells 2009 1.09
5 Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy. Cancer Res 2007 1.02
6 In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences. PLoS One 2009 1.02
7 Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity. J Biol Chem 2004 0.96
8 Enhanced antiangiogenic therapy with antibody-collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events. Int J Cancer 2006 0.92
9 Generation and characterization of monospecific and bispecific hexavalent trimerbodies. MAbs 2012 0.91
10 Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies. Proc Natl Acad Sci U S A 2013 0.90
11 Lymphocyte display: a novel antibody selection platform based on T cell activation. PLoS One 2009 0.88
12 Microencapsulation of therapeutic bispecific antibodies producing cells: immunotherapeutic organoids for cancer management. J Drug Target 2014 0.86
13 The heterotrimeric laminin coiled-coil domain exerts anti-adhesive effects and induces a pro-invasive phenotype. PLoS One 2012 0.85
14 Bacterial tubulin distinct loop sequences and primitive assembly properties support its origin from a eukaryotic tubulin ancestor. J Biol Chem 2011 0.84
15 Engineering human cells for in vivo secretion of antibody and non-antibody therapeutic proteins. Curr Opin Biotechnol 2011 0.83
16 Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab. Med Oncol 2013 0.83
17 The therapeutic potential of engineered human neovessels for cell-based gene therapy. Expert Opin Biol Ther 2010 0.83
18 Antibody gene therapy: getting closer to clinical application? Curr Gene Ther 2013 0.81
19 Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I. Immunology 2006 0.80
20 Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells. Cancer Gene Ther 2005 0.79
21 Engineered human tumor xenografts with functional human vascular networks. Microvasc Res 2010 0.79
22 Magnetic isolation of Plasmodium falciparum schizonts iRBCs to generate a high parasitaemia and synchronized in vitro culture. Malar J 2014 0.78
23 Efficient production of single-chain fragment variable-based N-terminal trimerbodies in Pichia pastoris. Microb Cell Fact 2014 0.78
24 Basement membrane-rich organoids with functional human blood vessels are permissive niches for human breast cancer metastasis. PLoS One 2013 0.77
25 Tumor cell surface display of immunoglobulin heavy chain Fc by gene transfer as a means to mimic antibody therapy. Hum Gene Ther 2005 0.76
26 In vivo selection of tumor-specific antibodies. Oncotarget 2013 0.76
27 Comment on "Production of multivalent protein binders using a self-trimerization collagen-like peptide scaffold". FASEB J 2008 0.75
28 Bacterial secretion of soluble and functional trivalent scFv-based N-terminal trimerbodies. AMB Express 2015 0.75
29 Functionally fused antibodies--a novel adjuvant fusion system. J Immunol Methods 2008 0.75